Tuesday's Top 6 Pre-Market Gainers Explained

Loading...
Loading...
  • Sarepta Therapeutics Inc SRPT was up 28.97 percent after the FDA requested Dystrophin data prior to making a decision on Eteplirsen NDA in addition to Wedbush upgrading the company to Outperform with a price target of $36.00.
  • United Natural Foods, Inc. UNFI rose 10.74 percent following its better-than-expected earnings for its third quarter and raised 2016 FY16 outlook.
  • Zillow Group, Inc.-Class A ZG jumped 10.45 percent after Barclays upgraded Zillow to Neutral following Zillow paying $130 million to settle News Corp NWSA/NAR litigation, which originally was estimated to be at least $500 million, according to Barclays.
  • Related Link: Zillow Just Removed A "Significant Overhang"; Class A Shares Up +9% In Pre-Market

  • Tribune Publishing Co TPUB traded up 1.54 percent after Gannet Co Inc GCI issued a statement regarding its $15.00 per share all-cash premium offer to acquire Tribune Publishing, thanks stockholders of Tribune to withhold vote at Tribune Annual Meeting.
  • Regulus Therapeutics Inc RGLS was trading up 4.71 percent after announcing positive top-line data on Hepatitis C virus treatment.
  • Williams Companies Inc WMB rose 3.08 percent after Energy Transfer Equity LP ETE reported election deadline for Williams Company.
  • Market News and Data brought to you by Benzinga APIs
    Posted In: Long IdeasNewsPre-Market OutlookMoversTrading IdeasdystrophineteplirsenWedbush
    Benzinga simplifies the market for smarter investing

    Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

    Join Now: Free!

    Loading...